FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

36463611000001109: Lidocaine 100mg/5ml (2%) solution for injection Mini-Plasco ampoules (hameln pharma Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 26-Dec 2018. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
1305801000001119 Lidocaine 100mg/5ml (2%) solution for injection Mini-Plasco ampoules (hameln pharma Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
1305821000001114 Lidocaine 100mg/5ml (2%) solution for injection Mini-Plasco ampoules (hameln pharma Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Lidocaine 100mg/5ml (2%) solution for injection Mini-Plasco ampoules (hameln pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Lidocaine 100mg/5ml (2%) solution for injection Mini-Plasco ampoules (hameln pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Lidocaine 100mg/5ml (2%) solution for injection Mini-Plasco ampoules (hameln pharma Ltd) Is a Lidocaine 100mg/5ml (2%) solution for injection ampoules true Inferred relationship Existential restriction modifier
Lidocaine 100mg/5ml (2%) solution for injection Mini-Plasco ampoules (hameln pharma Ltd) Has active ingredient Lidocaine true Inferred relationship Existential restriction modifier
Lidocaine 100mg/5ml (2%) solution for injection Mini-Plasco ampoules (hameln pharma Ltd) Has manufactured dose form Conventional release solution for injection true Inferred relationship Existential restriction modifier
Lidocaine 100mg/5ml (2%) solution for injection Mini-Plasco ampoules (hameln pharma Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Lidocaine 100mg/5ml (2%) solution for injection Mini-Plasco ampoules (hameln pharma Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Lidocaine 100mg/5ml (2%) solution for injection Mini-Plasco ampoules (hameln pharma Ltd) Has specific active ingredient Lidocaine hydrochloride true Inferred relationship Existential restriction modifier
Lidocaine 100mg/5ml (2%) solution for injection Mini-Plasco ampoules (hameln pharma Ltd) Has dispensed dose form Conventional release solution for injection true Inferred relationship Existential restriction modifier
Lidocaine 100mg/5ml (2%) solution for injection Mini-Plasco ampoules (hameln pharma Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Lidocaine 100mg/5ml (2%) solution for injection Mini-Plasco ampoules (hameln pharma Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Lidocaine 100mg/5ml (2%) solution for injection Mini-Plasco ampoules (hameln pharma Ltd) 20 ampoule Has AMP True Lidocaine 100mg/5ml (2%) solution for injection Mini-Plasco ampoules (hameln pharma Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start